perifosine has been researched along with Lymph Node Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, R; Liang, S; Liu, D; Wang, X; Xu, H; Xu, Z; Yang, L; Zhang, Z | 1 |
| Baetz, T; Belanger, K; Davis, M; Eisenhauer, E; Ernst, DS; Lohmann, R; Smylie, M; Wainman, N | 1 |
| Benson, AB; Levy, DE; Marsh, Rde W; Mitchell, EP; Rocha Lima, CM; Rowland, KM | 1 |
2 trial(s) available for perifosine and Lymph Node Metastasis
| Article | Year |
|---|---|
Phase II study of perifosine in previously untreated patients with metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Arthralgia; Chondrocalcinosis; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Middle Aged; Phosphorylcholine | 2005 |
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antiemetics; Child; Disease Progression; Drug Administration Schedule; Female; Humans; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Patient Selection; Phosphorylcholine; Survival Analysis | 2007 |
1 other study(ies) available for perifosine and Lymph Node Metastasis
| Article | Year |
|---|---|
Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.
Topics: Adult; Aged; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Progression; Down-Regulation; Eukaryotic Initiation Factor-4E; Female; Gene Expression; Humans; Inhibitory Concentration 50; Lymphatic Metastasis; Male; Middle Aged; Phosphorylcholine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Stomach Neoplasms; Up-Regulation | 2013 |